OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?
Published in:
Chemotherapy Research & Practice, 2017, p. 1, doi. 10.1155/2017/8196434
By:
- Joshi, Amit;
- Noronha, Vanita;
- Patil, Vijay M.;
- Chougule, Anuradha;
- Bhattacharjee, Atanu;
- Kumar, Rajiv;
- Goud, Supriya;
- More, Sucheta;
- Ramaswamy, Anant;
- Karpe, Ashay;
- Pande, Nikhil;
- Chandrasekharan, Arun;
- Goel, Alok;
- Talreja, Vikas;
- Mahajan, Abhishek;
- Janu, Amit;
- Purandare, Nilendu;
- Prabhash, Kumar
Publication type:
Article
Phase III randomized trial comparing intravenous to oral iron in patients with cancer‐related iron deficiency anemia not on erythropoiesis stimulating agents.
Published in:
Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 2, p. e129, doi. 10.1111/ajco.12762
By:
- Noronha, Vanita;
- Joshi, Amit;
- Patil, Vijay Maruti;
- Banavali, Shripad D.;
- Gupta, Sudeep;
- Parikh, Purvish M.;
- Marfatia, Shalaka;
- Punatar, Sachin;
- More, Sucheta;
- Goud, Supriya;
- Nakti, Dipti;
- Prabhash, Kumar
Publication type:
Article
Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer.
Published in:
International Journal of Cancer, 2024, v. 155, n. 12, p. 2232, doi. 10.1002/ijc.35111
By:
- Noronha, Vanita;
- Patil, Vijay Maruti;
- Menon, Nandini;
- Goud, Supriya;
- Singh, Ajaykumar;
- Shah, Minit;
- More, Sucheta;
- Shah, Srushti;
- Yadav, Akanksha;
- Sonawane, Sonali;
- Nawale, Kavita;
- Chowdhury, Oindrila Roy;
- Kaushal, Rajiv Kumar;
- Ghosh‐Laskar, Sarbani;
- Agarwal, Jai Prakash;
- Yadav, Subhash;
- Pai, Trupti;
- Janu, Amit;
- Mahajan, Abhishek;
- Purandare, Nilendu
Publication type:
Article
An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings.
Published in:
Ecancermedicalscience, 2021, v. 15, n. 1264-1315, p. 1, doi. 10.3332/ecancer.2021.1274
By:
- Kapoor, Akhil;
- Noronha, Vanita;
- Joshi, Amit;
- Patil, Vijay M.;
- Menon, Nandini;
- Bollam, Rajesh;
- Talreja, Vikas;
- Goud, Supriya;
- More, Sucheta;
- Solanki, Leena;
- Shah, Srushti;
- Chougule, Anuradha;
- Mahajan, Abhishek;
- Prabhash, Kumar
Publication type:
Article
Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study.
Published in:
Ecancermedicalscience, 2018, v. 12, n. 875-886, p. 1, doi. 10.3332/ecancer.2018.876
By:
- Joshi, Amit;
- Kate, Shruti;
- Noronha, Vanita;
- Patil, Vijay;
- Trivedi, Vaishakhi;
- Goud, Supriya;
- More, Sucheta;
- Bhairva, Sandeep;
- Prabhash, Kumar
Publication type:
Article
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapy.
Published in:
Ecancermedicalscience, 2017, v. 11, n. 770-791, p. 1, doi. 10.3332/ecancer.2017.776
By:
- Noronha, Vanita;
- Patil, Vijay;
- Joshi, Amit;
- Chougule, Anuradha;
- Bhattacharjee, Atanu;
- Kumar, Rajiv;
- More, Sucheta;
- Goud, Supriya;
- Karpe, Ashay;
- Ramaswamy, Anant;
- Pande, Nikhil;
- Chandrasekharan, Arun;
- Goel, Alok;
- Talreja, Vikas;
- Mahajan, Abhishek;
- Janu, Amit;
- Purandare, Nilendu;
- Prabhash, Kumar
Publication type:
Article
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?
Published in:
Lung India, 2018, v. 35, n. 1, p. 27, doi. 10.4103/lungindia.lungindia_201_17
By:
- Joshi, Amit;
- Patil, Vijay;
- Noronha, Vanita;
- Chougule, Anuradha;
- Bhattacharjee, Atanu;
- Kumar, Rajiv;
- Goud, Supriya;
- More, Sucheta;
- Ramaswamy, Anant;
- Karpe, Ashay;
- Pande, Nikhil;
- Chandrasekharan, Arun;
- Goel, Alok;
- Talreja, Vikas;
- Mahajan, Abhishek;
- Janu, Amit;
- Purandare, Nilendu;
- Prabhash, Kumar
Publication type:
Article
Phase III randomized controlled trial of gefitinib versus chemotherapy in EGFR-positive treatment-naïve metastatic lung cancer: Long-term outcome after eight years.
Published in:
Cancer Research, Statistics & Treatment, 2024, v. 7, n. 1, p. 19, doi. 10.4103/crst.crst_307_23
By:
- SINGH, AJAYKUMAR;
- PATIL, VIJAY;
- MENON, NANDINI;
- MORE, SUCHETA;
- JAIN, SRUSHTI;
- GOUD, SUPRIYA;
- SHAH, DARSHIT;
- SHAH, MINIT;
- JOBANPUTRA, KUNAL;
- UBHARAY, AHMAD
Publication type:
Article
Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial.
Published in:
Indian Journal of Medical & Paediatric Oncology, 2018, v. 39, n. 4, p. 493, doi. 10.4103/ijmpo.ijmpo_219_17
By:
- Noronha, Vanita;
- Pandey, Avinash;
- Patil, Vijay;
- Joshi, Amit;
- Choughule, Anuradha Bharat;
- Bhattacharjee, Atanu;
- Kumar, Rajiv;
- Goud, Supriya;
- More, Sucheta;
- Ramaswamy, Anant;
- Karpe, Ashay;
- Pande, Nikhil;
- Chandrasekharan, Arun;
- Goel, Alok;
- Talreja, Vikas;
- Mahajan, Abhishek;
- Janu, Amit;
- Purandare, Nilendu;
- Prabhash, Kumar
Publication type:
Article
Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study.
Published in:
Medical Oncology, 2024, v. 41, n. 1, p. 1, doi. 10.1007/s12032-023-02234-z
By:
- Noronha, Vanita;
- Patil, Vijay;
- Menon, Nandini;
- Kalra, Devanshi;
- Singh, Ajaykumar;
- Shah, Minit;
- Goud, Supriya;
- Jobanputra, Kunal;
- Nawale, Kavita;
- Shah, Srushti;
- Chowdhury, Oindrila Roy;
- Mathrudev, Vijayalakshmi;
- Jogdhankar, Shweta;
- Singh, Madhu Yadav;
- Singh, Ashish;
- Adak, Supriya;
- Sandesh, Mayuri;
- Arunkumar, R.;
- Kumar, Suman;
- Mahajan, Abhishek
Publication type:
Article

Found: 10